Latest filing published 28 Jul 2025 for Oncology Institute, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Richard A. Barasch is a declared insider at 5 companies (board member); the most frequent names are Universal American Corp., Universal American Financial Corp and Starling Oncology, Inc. The record holds 223 filings, for trades running from 30 December 2005 to 24 July 2025.
The open-market side counts 18 purchases for €2.9M alongside 25 sales for €5.7M. On balance, insiders were net sellers of €2.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 65 share grants and 12 option exercises. So far in 2025, the count stands at 1 purchase and no sales.
A typical purchase (the median) is worth €6,433. On 1 out of 13 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 28 July 2025, reports a transaction in Starling Oncology, Inc. The latest purchase dates back some time: it was published 575 days ago, on 28 March 2025. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 45 declarations